Terazosin Hydrochloride Anhydrous
- Product NDC
- 51079-936
- 11-digit product format
- 510790936
- Labeler code
- 51079
- Product ID
- 51079-936_9af1cfd2-0dea-a218-e053-2995a90a4efd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin hydrochloride anhydrous
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA075140
- Marketing category
- ANDA
- Marketing start
- 2000-04-01
- Marketing end
- 2021-01-31
- Substance
- TERAZOSIN HYDROCHLORIDE ANHYDROUS
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record